Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0085631 (agitation)
 12,064 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Phencyclidine (PCP) is a popular illicit drug often misrepresented as some other hallucinogenic substance and distributed in widely varying dosage forms and strengths. Users of hallucinogenic drugs may present with unintentional PCP overdoses. Toxicological laboratory analyses are essential to establish the diagnosis. In nine admitted overdose patients, the consciousness level ranged from alert to comatose on presentation, and all showed a prolonged recovery phase with agitation and toxic psychosis. Severe behavior disorder, paranoid ideation, and amnesia for the entire period of in-hospital stay are characteristic. In very high dose patients, shallow respiratory excursions and periods of apnoea and cyanosis coincided with generalized extensor spasm and spasm of neck muscles. Excessive bronchial secretions, gross ataxia, opisthotonic posturing, and grimacing occur. PCP toxic psychosis should be considered in drug-abusing patients presenting with schizophrenic-like symptoms, psychosis, or other bizarre behavior, whether or not they admit to taking PCP.
 ...
PMID:Phencyclidine ingestion: drug abuse and psychosis. 728 52

Pneumonia accounts for nearly half of all admissions amongst children less than 5 years of age to health centres and hospitals in the highlands of Papua New Guinea. Until recently, the indications for the use of oxygen in the management of childhood pneumonia in Papua New Guinea had been confined to the detection of cyanosis and restlessness. Oxygen is, however, difficult to deliver to many parts of Papua New Guinea, leading to high transport costs and shortages. Health workers in rural areas are continually faced with decisions as to which children should be given oxygen when it is in short supply. This study related clinical signs to the oxygen saturation of the blood using a pulse oximeter, in order to offer rational criteria for the use of oxygen in health centres and hospitals in remote areas. Data were collected on 110 children who were admitted to Tari Hospital with a diagnosis of moderate or severe pneumonia. Following admission, assessments were repeated at 12-hourly intervals until the child was discharged from the intensive nursing ward. All clinical assessments and oximetry readings were taken by a registered nurse. A rule developed via quadratic discrimination analysis was able to correctly classify 80 per cent of children as having adequate/inadequate oxygen saturation, with 'inadequate oxygen saturation' defined as less than 85 per cent. This, however, involved a complicated equation which would not be suitable for general use in a developing country. The use of a 'clinical score' using a summation of the major clinical signs was not found to offer any advantage over the recognition of any one of four 'indicator' signs.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Predicting hypoxia in children with acute lower respiratory infection: a study in the highlands of Papua New Guinea. 756 69

Acute respiratory infection (ARI) is responsible for many childhood deaths in developing countries, particularly deaths of children less than six months old. A major risk factor for death in children with ARI is hypoxia, which is oxygen saturation of 90% in the blood, but administration of oxygen is rare and, when it is administered, clinicians tend to use it when the children become so severely ill that their outcome is poor. Oxygen is not readily available in developing countries. Administration of oxygen earlier in the course of ARI may improve outcome and prevent deterioration. In Papua New Guinea, standard treatment manuals list indications for oxygen use as cardiac failure, grunting, drowsiness, and apneic episodes, in addition to cyanosis and restlessness. Indications that significantly increase diagnosis of hypoxemia and therefore the need for oxygen, although they are not clear cut, include either cyanosis or grunting together with an increased respiratory rate. Use of pulse oximeters would facilitate decisions to use oxygen, but they are cost-prohibitive for developing countries, except in a few well-equipped health facilities. A pragmatic approach to making a decision on what child receives oxygen is administration of a test dose and monitoring the child's response after 24 hours of oxygen therapy. If the child's condition improves, oxygen treatment should continue. Rational criteria are needed to facilitate the decision to stop giving oxygen to a child who does not respond, however. Oxygen concentrators may improve management of childhood pneumonia in developing countries and would be more cost-effective than conventional bottled oxygen. Yet, oxygen concentrators depend on a reliable electricity source. Providers should use an intranasal catheter to administer oxygen to children with pneumonia, since it is less wasteful (50% oxygen concentration at low rate of 0.5 l/min) and safer should the tube disconnect.
 ...
PMID:Hypoxia in childhood pneumonia: better detection and more oxygen needed in developing countries. 829 86

Patients with neuromuscular disease may suffer from nocturnal respiratory failure despite normal daytime respiratory function. The physiological reduction in muscle tone during sleep may be life-threatening in a patient with impaired muscle strength. Nocturnal respiratory failure may occur in patients with the postpolio syndrome, amyotrophic lateral sclerosis, myasthenia gravis, myotonic dystrophy, and muscular dystrophy. Diagnosis of obstructive, central and mixed apneas, hypopneas, and hypoventilation is best made using polysomnography. Therapeutic options include noninvasive ventilation such as continuous positive airway pressure, bilevel positive airway pressure, intermittent positive pressure ventilation and, rarely, tracheostomy, oxygen, or protriptyline. Evaluation by a sleep specialist should be initiated in any neuromuscular patient with nocturnal symptoms such as air hunger, intermittent snoring or breathing, orthopnea, cyanosis, restlessness, and insomnia. Daytime symptoms may include morning drowsiness, headaches and excessive daytime sleepiness. Polycythemia, hypertension, and signs of heart failure may also be seen. Effective treatment is available, and may improve the quality of life, and possibly increase survival.
 ...
PMID:Nocturnal respiratory failure as an indication of noninvasive ventilation in the patient with neuromuscular disease. 967 Mar 10

Supraventricular tachycardia (SVT) is the most common sustained arrhythmia to present in the neonatal and infancy age group. Predisposing factors (congenital heart disease, drug administration, illness and fever) occur only in 15% of infants. The presentation of SVT in the neonate is frequently subtle, and may include pallor, cyanosis, restlessness, irritability, feeding difficulty, tachypnea, diaphoresis and grunting. Congestive heart failure is more common in infants under 4 months of age (35% incidence). Age-related differences in the distribution of SVT mechanisms occur in different age groups. In infants under 1 year of age, the mechanisms underlying SVT are atrial tachycardia (15%), AV nodal re-entry tachycardia (5%), and AV reciprocating tachycardia (80%). Options for acute management include: use of the diving reflex, intravenous adenosine, transesophageal pacing, and cardioversion. Intravenous administration of verapamil should be avoided. Data regarding freedom from recurrence of untreated SVT in the first year of life are limited, and may be in the range of 25-60%. Chronic therapy with digoxin, beta-blockers, flecainide, sotalol and amiodarone has proved effective in controlling recurrent episodes of SVT. Radiofrequency ablation can be employed successfully in medically refractory cases, but should be avoided in this age group (increased complication rate).
 ...
PMID:Supraventricular tachycardia in the neonate and infant. 1082 87

We evaluated the use of midazolam versus thiopental in 50 children with refractory status epilepticus (RSE), admitted in a pediatric intensive care unit. The study consisted of two groups of patients: Group A - Midazolam, a prospective study, and Group B - Thiopental, a historical group. These patients already had previous medication with benzodiazepin and diphenylhydantoin and other drugs. When there was no effective control of the seizures, the patients of Group A received midazolam of 200 microg/kg intravenous in bolus, being followed by continuous intravenous infusion at the rate 0. 25-15 microg/kg/min. Group B received thiopental 1 mg/kg intravenous in bolus followed by continuous intravenous infusion at the rate of 10-120 microg/kg/min. In relation to the time of seizure control and effectiveness, there was no statistical significance for the two groups. The Midazolam Group had significantly less complications during the treatment: less cyanosis (p=0.00006), and they did not need respiratory support (p<0.00001). When the therapy with midazolam was ceased, 12.5% of the patients from this group showed psychological disorders such as mental confusion, aggressive behavior, restlessness, hallucinations and agitation.
 ...
PMID:[Comparative non-randomized study with midazolam versus thiopental in children with refractory status epilepticus]. 1084 28

Oxygen administration is one of the most important modalities of therapy for a patient with hypoxaemia to prevent death and disability from common conditions such as acute lower respiratory tract infections. Oxygen needs to be available at all times in hospitals, however, it is too expensive for many developing countries. There is little information for health professionals regarding indications for initiating oxygen therapy, selecting appropriate method of oxygen administration and deciding on the source for oxygen. A review of the literature using medline citations and cross references from published articles and other manuscripts was made. The review described the two main sources of oxygen for small hospital-cylinders and oxygen concentrators and their advantages and disadvantages. It also looked at the evidences for clinical indications to initiate and discontinue oxygen therapy. Studies on efficient and safe methods of administration of oxygen were reviewed as well. The review concluded that oxygen may be administered in children with cyanosis, chest indrawing, inability to drink or breastfeed, tachypnea with respiratory rate above 70/minute or in a child who develops restlessness and improves on oxygen. The initial capital cost of concentrators is high but the running cost is low and it does not require transport while oxygen cylinders are expensive to transport and need continuous refilling. The safest method of oxygen administration are the prongs followed by the nasal catheters.
 ...
PMID:Oxygen therapy for children with acute respiratory infections in small hospitals. 1114 81

The acute toxicity of dried Nerium oleander leaves to Najdi sheep is described in 12 sheep assigned as untreated controls, N. oleander-treated once at 1 and 0.25 g/kg body weight and N. oleander-treated daily at 0.06 g/kg body weight by drench. Single oral doses of 1 or 0.25 g of dried N. oleander leaves/kg body weight caused restlessness, chewing movements of the jaws, dyspnea, ruminal bloat, incoordination of movements, limb paresis, recumbency and death 4-24 hr after dosing. Lesions were widespread congestion or hemorrhage, pulmonary cyanosis and emphysema, hepatorenal fatty change and catarrhal abomasitis and enteritis. The daily oral doses of 0.06 g dried N. oleander leaves/kg body weight caused less severe signs and death occurred between days 3 and 14. In these animals, the main lesions were hepatonephropathy and gelatinization of the renal pelvis and mesentry and were accompanied by significant increases in serum AST and LDH activities, in bilirubin, cholesterol and urea concentrations and significant decreases in total protein and albumin levels, anemia and leucopenia.
 ...
PMID:Acute toxicity of various oral doses of dried Nerium oleander leaves in sheep. 1178 96

Neonatal diabetes mellitus (NDM) is defined as hyperglycemia occurring in the first few weeks of life. It can be either transient (TNDM) or permanent (PNDM). A 25 days old newborn was brought to the hospital with restlessness, respiratory depression and cyanosis. He was born at term with a birth weight of 2,000 g. There was no consanguinity between his parents. His physical examination findings were as follows: Weight and height were under 3th percentile, he was hypoactive and dehydrated. Serum glucose level was 800 mg/dl; C-peptide was 0.41 ng/ml. Upon investigation for dyslipidemia in association with his neonatal diabetes, hyperchylomicronemia was found both in the patient and his father. Pancreatitis, anemia and cholestasis were also observed. Insulin treatment was started for his diabetes together with a special diet for dyslipidemia. At the end of 28 months of follow-up, dyslipidemia has resolved but the need for insulin therapy was still existing. However, TNDM was considered in differential diagnosis because he was small for gestational age (SGA) at birth and his symptoms had started at the 25th day of the neonatal period. Delayed recovery from insulin dependency brought out the possibility of PNDM. Furthermore, neonatal diabetes combined with hypechylomicronemia is a rare clinical picture. Reported cases of NDM with different clinical evaluation will help to better understanding of this disorder.
 ...
PMID:Neonatal diabetes with hyperchylomicronemia. 1255 65

Dyspnea is a subjective sensation of breathlessness. This distressing symptom is experienced by many patients with lung cancer and often is accompanied by physiologic signs and symptoms, such as tachypnea, tachycardia, pallor, and cyanosis. Dyspnea-induced hypoxia may occur and cause confusion, cognitive impairment, and restlessness. Prompt and accurate nursing assessment of dyspnea can assist in identifying appropriate treatment interventions. Supplemental oxygenation and medications, along with treatment of the underlying cause of the dyspnea, may promote patient comfort. Nurses need to be skilled in assessing dyspnea experienced by patients with lung cancer and knowledgeable in implementing effective symptom management techniques.
 ...
PMID:Nursing assessment and management of dyspneic patients with lung cancer. 1279 41


<< Previous 1 2 3 4 Next >>